A simple, seed-stage cap table with one 1× non-participating preference for cash actually invested: Founder Common (the upside + control), two junior Class B Preferred holders (legacy cash), a small goodwill layer, and this round's SAFE converting into senior Class A Preferred. The phantom-equity pool is shown as an overhang, not buried — and there are no options.
| Holder / group | Shares | % | Class |
|---|---|---|---|
| Harry Massey (founder) | 8,932,444 | 89.32% | Founder Common |
| Massey Developments Ltd — legacy cash ($3.2M, priced at the $73M cap; preference pegged to cost) | 438,356 | 4.38% | Class B Preferred |
| Kitty Stoneburner / Healing Frequencies — legacy cash (~$1.6M, restricted) | 218,000 | 2.18% | Class B Preferred |
| Legacy goodwill grants (investors & employees) | 411,200 | 4.11% | Common |
| Total issued | 10,000,000 | 100.00% |
Class B Preferred is the legacy cash actually invested — Massey Developments' $3.2M (the founder's holding company; shares priced at the $73M cap — $7.30/share, the same price as every other investor — with the preference pegged to the $3.2M cost) and Kitty Stoneburner's ~$1.6M restricted preferred (2.18% ≈ $1.6M at the $73M merge price) — 1× non-participating and junior to the new money. The goodwill Common grants are discretionary: former cash investors mirror their prior percentage; former employees receive a goodwill grant. These grants are gratuitous and confer no rights over the restructuring.
| Holder / group | Class | Shares | % post-conv. |
|---|---|---|---|
| Harry Massey (founder) | Founder Common | 8,932,444 | 83.21% |
| Massey Developments Ltd | Class B Preferred (junior) | 438,356 | 4.08% |
| Kitty Stoneburner / Healing Frequencies | Class B Preferred (junior) | 218,000 | 2.03% |
| Legacy goodwill | Common | 411,200 | 3.83% |
| SAFE investors (as-converted) | Class A Preferred (senior) | 735,294 | 6.85% |
| Total | 10,735,294 | 100.00% |
The SAFE carries a $73M post-money valuation cap plus a 15% discount, converting at the lower of the two, so the exact percentage is set at the Series A. The table shows conversion at the $73M cap — this round's floor: $5.0M ÷ $73M = 6.85% (new shares = 10,000,000 × (0.0685 ÷ 0.9315) = 735,294). The 15% discount only ever gives SAFE holders more: it governs for any Series A below ~$86M (≈8.1% at a $73M round, ≈10% at ≈$59M). Context on value: E4L is a new company that starts with acquired products, ~650 practitioners and recurring revenue from day one — not a concept waiting for its first customer. There is no option/ESOP pool; incentives run through the phantom-equity pool below.
The founder's economics sit in ordinary Founder Common held personally by Harry Massey — the same per-share economics as every other common share, carrying the enterprise upside (capital-gains / QSBS-friendly). His holding company, Massey Developments Ltd, contributed the acquired assets but deliberately took only $3.2M of Class B Preferred — its acquisition cost, ranking junior to the new money — with no repayable note or royalty. That $3.2M reflects roughly $15–20M of real invested capital built over 20+ years (reinvested funding, $3.2M+ of loans, two decades of IP development, the customer base and the operating subsidiaries) — context for the founder's commitment, not the value of Massey's stock. Those subsidiaries include NES Health LLC, which owns the FIELD diagnostic platform; the Company therefore owns FIELD and the products outright, with no licence caveat.
Incentives run entirely through a 14% phantom-equity pool — contractual, cash-settled value rights measured against company value on defined events. These are not shares and not options: no votes, no cap-table entry. The pool is shown here as an overhang, and in the Disclosure Memorandum, because its economic effect is dilution-equivalent. There are no stock options.
| Holder | Phantom % | Terms |
|---|---|---|
| Prof. Hemal Patel | 1.0% | Advisor value right, fully vested (IRC §409A review) |
| Susan Kichuk | 5.0% | Board Advisor value right; continuing a 4-year vest begun late 2025, over the remaining ~3 years |
| Steve McCardell | 1.5% | Contributor value right, approximately half vested; $35M company-value hurdle |
| Tony Watson | 4.0% | Team value right |
| Named awards | 11.5% | of the 14% pool, in the four awards above |
| Reserved for future team | 2.5% | Headroom, unallocated within the pool |
| Total pool | 14.0% | of company value on a payout event |
Confidential. For accredited investors only. Securities offered under Rule 506(c) of Regulation D; accredited status is verified before any subscription is accepted. Share counts and percentages are illustrative; the Disclosure Memorandum governs. Company name to be conformed to the name on the Company’s filed Nevada charter. Post-conversion figures rounded for illustration.
E4L, Inc. · Salt Lake City, Utah · harry.massey@e4l.com · © 2026